Icure Pharmaceutical Incorporation (KOSDAQ:175250)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,995.00
-95.00 (-4.55%)
At close: Jun 27, 2025, 3:30 PM KST
-19.56%
Market Cap 73.13B
Revenue (ttm) 75.40B
Net Income (ttm) 3.43B
Shares Out 37.37M
EPS (ttm) 91.00
PE Ratio 21.51
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 122,690
Average Volume 164,285
Open 2,030.00
Previous Close 2,090.00
Day's Range 1,977.00 - 2,090.00
52-Week Range 1,399.00 - 3,490.00
Beta 0.66
RSI 51.96
Earnings Date Aug 14, 2025

About KOSDAQ:175250

Icure Pharmaceutical Incorporation, a biopharmaceutical company, researches, develops, and sells pharmaceutical and cosmetic products in South Korea. The company offers functional, nature-derived, derma, and customized cosmetics products. It also offers eye gel, hydro nude gel, lip gel mask, and functional patch products; and sheet, mud, foil, and melting masks. In addition, the company provides body and haircare products, including naturally derived hair and baby line, cleansing tissue, and wet wipes. Further, it offers perfumes, textile perfu... [Read more]

Industry Perfumes, Cosmetics, and Other Toilet Preparations
Founded 2000
Employees 210
Stock Exchange KOSDAQ
Ticker Symbol 175250
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.